Bayer HealthCare Diagnostics working on autoimmune tests
Hycor Biomedical Inc. and the Diagnostics Division of Bayer HealthCare LLC, a member of the Bayer Group announced the signing of an exclusive, worldwide agreement for the development of autoimmune tests. Under the terms of the agreement, Hycor will develop and manufacture a broad menu of tests for the ADVIA Centaur® Immunoassay System. This laboratory testing system offers a broad range of tests for cancer, cardiovascular, fertility, allergy, anemia, thyrosis and infectious diseases. Bayer HealthCare Diagnostics' will retain exclusive rights to market the product. "Automating autoimmune testing on the ADVIA Centaur® system will provide laboratorians with significant productivity enhancements, while providing readily available and quality test results to clinicians," said Hans Hiller, PhD, senior vice-president laboratory testing segment, Bayer HealthCare LLC, Diagnostics Division. "Hycor's expertise in the development and manufacturing of autoimmune tests will enable us to offer customers high quality autoimmune products."
Estimated at $126 million, the autoimmune testing market is poised to grow significantly as the testing methodology shifts, new therapeutics are developed, and the population ages.
According to The American Autoimmune Related Diseases Association (AARD), there are over 80 autoimmune diseases, which affect 50 million Americans, the majority being women. Autoimmune diseases include multiple sclerosis, juvenile diabetes, scleroderma, lupus, rheumatoid arthritis, and chronic active hepatitis. These diseases cost over $86 billion annually in health care costs and are the third leading cause of death and disability, following heart disease and cancer.
Other news from the department research and development

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.